“The ratio of stearic acid (C18:0) to oleic acid (C18:1) in the liver was increased by olmesartan , indicating a reduction in the in vivo activity of SCD-1.ConclusionsARB ameliorates hepatic steatosis and insulin resistance in obese fa/fa Zucker rats fed a high-fat diet.”